The most practical consequence is simple: payments save lives by getting shots into arms faster. Randomized trials, like one published in Science, show modest cash incentives meaningfully boost vaccination uptake, especially among hesitant groups. We already pay for prevention through insurance and public health programs; a direct incentive is just the most efficient version of that. The cost per vaccinated person is trivial next to the cost of even one severe hospitalization, let alone an outbreak. If we want fewer deaths and fewer restrictions, paying people is the lever that actually works.

You raise a fair point: trust and intrinsic motivation matter in public health, and we shouldn't casually commodify something like vaccination. I won't dismiss that concern. But the evidence we have suggests the crowding-out worry is largely theoretical here. The randomized trial I cited found payments increased uptake precisely among hesitant groups; those people weren't suspicious because of the money, they were overcoming practical barriers like time off work and transport costs. Payment doesn't replace information campaigns, it complements them by removing frictions. And unlike a vague appeal to shared responsibility, a direct incentive produces measurable vaccination gains right now, which translates into fewer hospitalizations and deaths.

A randomized trial in rural India found that offering a small packet of lentils and a metal plate raised full childhood immunization from 38 percent to 53 percent—a 15-point jump for pennies. That is the kind of measurable result we need, not a vague hope about shared responsibility. You call payment economic pressure, but the choice stays voluntary: people can still refuse. And sustainability? Payment combined with information builds momentum; early adopters become living evidence that shots are safe, which sustains uptake after incentives end. Trust-based campaigns are fine in theory, but they have never moved the needle like this.